Cellular proteases involved in the pathogenicity of human immunodeficiency and influenza viruses

Advances in Experimental Medicine and Biology

Volumn 389, Issue , 1996, Pages 233-240

  Kido, Hiroshi ^a   Towatari, Takae ^a   Niwa, Yasuharu ^a   Okumura, Yuushi ^a   Beppu, Yoshihito ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PARAINFLUENZA VIRUS 1; PARAMYXOVIRIDAE; REOVIRUS SP.; RHINOVIRUS; VACCINIA; VACCINIA VIRUS;

SERINE PROTEINASE; TRYPTASE; TRYPTASE CLARA; TRYPTASE TL(2); BETA ADRENERGIC RECEPTOR; CD4 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE RECEPTOR; SIALIC ACID; VIRUS RECEPTOR;

BRONCHUS; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CYTOLOGY; ENZYMOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ORTHOMYXOVIRUS; PARAMYXOVIRUS; PATHOGENICITY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE; VIROLOGY; CELL ADHESION; CONFERENCE PAPER; ENZYME ACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; PROTEIN DEGRADATION; REOVIRUS; RHINOVIRUS; VACCINIA VIRUS; VIRUS REPLICATION;

BRONCHI; CD4-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; HIV-1; HUMANS; ORTHOMYXOVIRIDAE; RESPIROVIRUS; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0030339827     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0335-0_29     Document Type: Article

References (24)

1. Homma, M., and Ohuchi, M., 1973, Trypsin action on the growth of Sendai virus in tissue culture cell, J. Virol. 12: 1457-1465.
2. Klenk, H.-D., and Rott, R., 1988, The molecular biology of influenza virus pathogenicity, Adv. Virus Res. 34: 247-281.
3. Rott, R., 1979, Molecular basis of infectivity and pathogenicity of myxoviruses, Arch. Virol. 59: 285-298.
4. Scheid, A., and Choppin, P.W., 1974. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus, Virology 57: 475-490.
5. Maddon, P.J., Dalgleish, A.G., and McDougal, J.S., 1986, The T4 gerne encodes the AIDS vius receptor and is expressed in the immune system and the brain, Cell 47: 333-348.
6. Clapham, P.R., Blanc, D., and Weiss, R.A., 1991, Specific cell-surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and simian imunodeficiency virus, Virology 181: 703-715.
7. Hattori, T., Koito, A., Takatsuki, K., Kido, H., and Katunuma, N., 1989, Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection, FEBS Lett. 248: 48-52.
8. + lymphocytes immunologically rective with antibody inhibiting syncytia induced by HIV-1. Purification and charcterization, J. Biol. Chem. 265: 21979-21985.
9. + lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp120, FEBS Lett. 286: 233-236.
10. Tashiro, M., and Homma, M., 1983, Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs, Infect. Immun. 39: 879-888.
11. Tashoro, M., Yamakawa, M., Tobita, K., Klenk, H.-D., Rott, R., and Seto, J.T., 1990. Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium, J. Virol. 64: 3627-3634.
12. Kido, H., Yokoigoshi, Y., Sakai, K., Tashiro, M., Kishino, Y., Fukutomi, A., and Katunuma, N., 1997. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein, J. Biol. Chem. 267: 13573-13579.
13. Tashiro, M., Yokogoshi, Y., Tobita, K., Seto, J.T., Rott, R., and Kido, H., 1992, Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity, J. Virology 66: 7211-7216.
14. Kido, H., Sakai, K., Kishino, Y., and Tashiro, M., 1993, Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus, FEBS Lett., 322: 115-119.
15. Hu, S.H., Kosowski, S.G., and Dalrymple, J.M., 1986, Expression of AIDS virus envelope gene in recombinant vaccinia viruses, Nature 320: 537-540.
16. + cells, Virology 186: 313-317.
17. + lymphocytes. Purification and characterization, J. Biol. Chem. 268: 13406-13413.
18. Ivanoff, L.A., Looney, D.J., McDanal, C., Morris, J.F., Wong-Stal, F., Langlois, A.J., Petteway, S.R., and Matthews, T.J., 1991. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Res. Hum. Retroviruses 7: 595-603.
19. Javaherian, K., Langlois, A.J., McDanal, C., Ross, K.L., Eckler, L.L., Jellis, C.L., Profy, A.T., Rusche, J.R., Bolognesi, D.P., Putney, S.D., and Matthews, T.J., 1989, Principal neutralizing domain on the human immunodeficiency virus type I envelopoe protein, Proc. Natl. Acad. Sci. USA 86: 6768-6772.
20. Putney, S., 1992, How antibodies block HIV infection: paths to an AIDS vaccine, TIBS 17: 191-196.
21. Kido, H., Yokogoshi, Y., and Katunuma, N., 1988, Kunitz type protease inhibitor found in rat mast cell: purification, properties and amino acid sequence, J. Biol. Chem. 263: 18104-18107.
22. Werner, A., and Levy, J.A., 1993, Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4, J. Virology 67: 2566-2574.
23. Clements, G.J., Price-Jones, M.J., Stephens, P.E., Sutton, C., Schulz, T.F., Clapham, P.R., Mckeating, J.A., McClure, M.O., Thomson, S., Marsh, M., Kay, J., Weiss, R.A., and Moore, J.P., 1991, The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic clevage sites: a possible function in viral fusion, AIDS Research and Human Retroviruses 7:3-16.
24. Avril, L-E., Martino-Ferrer, M.D., Pignede, G., Seman, M., and Gauthier, F., 1994, Identification of the U-937 membrane-associated proteinase interacting with the V34 loop of HIV- gp120 as cathepsin G, FEBS Lett. 345: 81-86.